FUS-DDIT3 Prevents the Development of Adipocytic Precursors in Liposarcoma by Repressing PPARγ and C/EBPα and Activating eIF4E

• Pedro A. Pérez-Mancera,

  Affiliation Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC/ Universidad de Salamanca, Salamanca, Spain

  ⨯
• Camino Bermejo-Rodríguez,

  Affiliation Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC/ Universidad de Salamanca, Salamanca, Spain

  ⨯
• Manuel Sánchez-Martín,

  Affiliations Department of Medicine, University of Salamanca, Salamanca, Spain, Genetically Engineered Mouse Facility, SEA, University of Salamanca, Salamanca, Spain

  ⨯
• Fernando Abollo-Jiménez,

  Affiliation Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC/ Universidad de Salamanca, Salamanca, Spain

  ⨯
• Belén Pintado,

  Affiliation Genetically Engineered Mouse Facility, Centro Nacional de Biotecnología (CNB)- Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain

  ⨯
• Isidro Sánchez-García

  * E-mail: isg@usal.es

  Affiliation Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC/ Universidad de Salamanca, Salamanca, Spain

  ⨯